1st Global Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-938
Closed -$251K 527
2016
Q1
$251K Buy
938
+172
+22% +$49.2K 0.04% 397
2015
Q4
$239K Sell
766
-3,003
-80% -$894K 0.04% 367
2015
Q3
$1.02M Sell
3,769
-2,092
-36% -$643K 0.16% 86
2015
Q2
$1.78K Buy
5,861
+186
+3% +$55.5K 0.26% 44
2015
Q1
$1.69M Buy
5,675
+57
+1% +$16.3K 0.25% 51
2014
Q4
$1.45M Sell
5,618
-58
-1% -$14.5K 0.21% 58
2014
Q3
$1.37M Buy
5,676
+460
+9% +$103K 0.22% 55
2014
Q2
$1.16M Buy
5,216
+2,164
+71% +$448K 0.17% 73
2014
Q1
$628K Buy
3,052
+33
+1% +$6.54K 0.12% 139
2013
Q4
$507K Sell
3,019
-289
-9% -$45.2K 0.09% 163
2013
Q3
$476K Buy
+3,308
New +$441K 0.1% 154

Other funds holding AGN

1st Global Advisors's AGN Position: Q2 2016 in Review

1st Global Advisors sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 938 shares — an estimated $251K sold.

1st Global Advisors first reported a position in AGN in Q3 2013 and held it in 11 quarters. The position peaked at $1.69M in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • 1st Global Advisors reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • 1st Global Advisors sold 938 Allergan plc shares in Q2 2016, an estimated $251K.
  • 1st Global Advisors first reported a position in Allergan plc in Q3 2013 and held it in 11 quarters.
  • 1st Global Advisors's Allergan plc position peaked at $1.69M in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on 1st Global Advisors's 13F filing for Q2 2016, filed 21 Jul 2016.